Literature DB >> 9816032

Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic.

W Ki Hong1, S M Lippman, W N Hittelman, R Lotan.   

Abstract

Epithelial cancers in the lung and head and neck are a devastating group of diseases which account for approximately 35% of cancer deaths in the United States. Chemoprevention is a new strategy to block or reverse the carcinogenic process. Biological concepts including field carcinogenesis and multistep carcinogenesis strongly support the rationale for using chemopreventive approaches. Our group has focused on applications of translational retinoid studies to increase our knowledge of the molecular events in biology and chemoprevention. In this review, we will focus on four issues, biology, retinoids, retinoid clinical trials, and translational research, in the chemoprevention of aerodigestive cancers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9816032

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

Review 1.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

2.  Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).

Authors:  M M Webber; D Bello-DeOcampo; S Quader; N D Deocampo; W S Metcalfe; R M Sharp
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

3.  Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.

Authors:  A Franchi; O Gallo; I Sardi; M Santucci
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 4.  Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer.

Authors:  M Widschwendter; J Berger; H M Müller; A G Zeimet; C Marth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

Review 5.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

6.  Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer.

Authors:  C Jerónimo; R Henrique; J Oliveira; F Lobo; I Pais; M R Teixeira; C Lopes
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.

Authors:  Tatyana Ivanova; Anatolii Petrenko; Tatyana Gritsko; Svetlana Vinokourova; Ernest Eshilev; Vera Kobzeva; Fjodor Kisseljov; Natalia Kisseljova
Journal:  BMC Cancer       Date:  2002-03-21       Impact factor: 4.430

8.  Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.

Authors:  N Ariga; T Moriya; T Suzuki; M Kimura; N Ohuchi; H Sasano
Journal:  Jpn J Cancer Res       Date:  2000-11

9.  The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil.

Authors:  Muneyuki Masuda; Satoshi Toh; Koji Koike; Yuichiro Kuratomi; Masumi Suzui; Atsuko Deguchi; Sohtaro Komiyama; I Bernard Weinstein
Journal:  Jpn J Cancer Res       Date:  2002-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.